//
Safety and feasibility of robotic percutaneous coronary intervention: PRECISE (Percutaneous Robotically-Enhanced Coronary Intervention) Study
How Low to Go With Glucose, Cholesterol, and Blood Pressure in Primary Prevention of CVD
Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or with Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights from the AUGUSTUS Trial
Randomized Comparison of Ridaforolimus-Eluting and Zotarolimus-Eluting Coronary Stents 2-Year Clinical Outcomes: From the BIONICS and NIREUS Trials
Qualitative and Mixed Methods Provide Unique Contributions to Outcomes Research
2017 ACC/AHA Blood Pressure Treatment Guideline Recommendations and Cardiovascular Risk
Routinely reported ejection fraction and mortality in clinical practice: where does the nadir of risk lie?
Defining Staged Procedures for Percutaneous Coronary Intervention Trials A Guidance Document